About PER - Products & Services

At Physicians' Education Resource (PER), our comprehensive programs are designed utilizing advanced adult educational principles in order to ensure that key learning objectives are identified, measured, and achieved.

Self-Directed and Lifelong Learning Programs

In addition to live meetings, PER publishes hundreds of print and Web-based educational activities in order to provide health care professionals with self-directed and on-demand learning. Publications include major meeting highlights, monographs, literature overviews, case studies, and supplements. Moreover, a variety of online-exclusive, innovative, oncology CME programs are available in several formats, thus providing learners with educational opportunities that best suit their learning style. For example, Integrated Oncology Learning and Communities of Oncology Practice were developed to take advantage of innovative methodologies to allow for collaborative and blended learning whereby interaction is stimulated, learning is fostered, new knowledge is gained, and best practices are identified and shared.

Online Activities

Integrated Oncology Learning—Pathways to Practice Improvement: A curriculum-based program consisting of one or more modules comprising related activities developed by a diverse team of experts in a variety of presentation formats.

  • CME-designated case based (clinical scenarios)
  • OncoLogue™
  • Expert interviews
  • On-demand videos and podcasts of live events
  • CME-certified newsletters
  • Live events

Communities of Oncology Practice: A series of CME-certified activities combining e-learning technology with instructor-led training and providing opportunities for educational activities and social networking at the local and regional level.

Live Course:

  • Moderator-conducted interview of an expert on his/her approach to patient management followed by a discussion open to the audience
  • Case-based workshop
  • Evidence-based summary
  • Online discussion forums and social networking

Online Course:

  • On-demand video from live course
  • Case Based

OncoLogue™: An online learning series initiating dialogue between learners and leading oncology experts

  • CME-certified online publication
  • Learners are asked to submit questions and clinical scenarios on the topic of the online publication for posting on the Web site.
  • On-demand online interview with an expert addressing the learner-submitted questions

Case based: CME-designated, online-exclusive interactive clinical scenarios

Virtual Tumor Boards and Grand Rounds: Developed in partnership with leading universities, associations, networks, and practices, an online learning series patterned after the traditional academic live format to provide the learner with highly focused expert updates and commentaries on current standards of therapy and evolving cancer care.

e-Lerts: Brief discussions by experts of key presentations from society meetings available as audio recordings with optional slide sets.

Expert Interviews: Video presentations of dialogues by experienced faculty on the practical applications of and challenges brought about by recently reported practice-changing data.

On-Demand Webcasts and Podcasts: Archived videos from live events available on the Web or downloadable and portable.

Print and online publications

CME-designated newsletters:

  • Early results publications
  • Clinical scenarios
  • Mature results publications
  • Journal clubs

Meeting highlights:

  • CME-designated summaries written by leading experts in the field

Multimedia publications, including CD-ROMs, from PER meetings

Live Meetings

In 2009, PER will provide over 100 live meetings comprising an impressive portfolio of programs ranging from international congresses to local community-based meetings, including:

Worldwide Multiday Congresses

Twenty-two multiday CME-designated meetings with 40-50 faculty and 8-15 supporters dedicated to educating health care providers on various diseases, treatments, and management as well as other topics of current interest:

By disease type:

  • Solid tumors: breast; colorectal; lung and head & neck; melanoma; prostate, kidney, bladder; ovarian
  • Hematologic malignancies: leukemia, lymphoma, myeloma, myelodysplastic syndromes, myeloproliferative disorders

By treatments and management:

  • Targeted therapies and monoclonal antibodies
  • Long-term management of patients undergoing stem cell transplantation
  • Supportive care

By topics:

  • "Oncology Nursing and Pharmacy"
  • "Clinical Challenges in Cancer Medicine for Community Oncologists (Fall Oncology)"
  • "Health Care Quality & Improvement Systems"
  • "Community Oncology Research"

Regional Meetings and Satellite Symposia

Fifty-one US-based regional 1/2- to 1-day CME-designated meetings with 10-15 faculty and 6-12 supporters

Ten international 1/2- to 1-day meetings

Sole-supported satellite meetings with optional live interactive Webcasts, including over 15 symposia at major congresses and global meetings

Local Meetings

PER offers 2 distinct types of Local Meetings:

Community Evening Meetings

  • Two-hour highly interactive CME-designated programs with audience participation facilitated by case-based discussions and question-and-answer sessions
  • Designed to update medical oncologists and hematologists on recent clinical trial data impacting physician practice

Nationally Broadcast Innovative Learning Programs

  • CME-designated meetings intended for practicing community oncologists nationally broadcast in high definition simultaneously to audiences in local restaurants throughout the country
  • Features interactive participation with each site, including live question transmission from all locations

Online CME Updates

NSCLC TODAY

Treatment of a 62-Year-Old Patient With Metastatic NSCLC After a Platinum Doublet

Get updates on the latest developments in maintenance therapy for patients with advanced non–small-cell lung cancer.

Go to activity >>

ADJUVANT THERAPY

Treatment of a 53-Year-Old Man With Stage IIA NSCLC

Learn about recent clinical data on adjuvant therapy in patients with resected early-stage non–small-cell lung cancer and the role of biomarkers in predicting benefit from adjuvant therapy. 

Get started >>

TREATMENT OPTIONS

E-Lert: Updates in Advanced Melanoma From the 46th Annual Meeting of ASCO

Advanced melanoma is a difficult-to-treat malignancy. Listen and find out about novel therapies in recent clinical trials to treat patients with advanced melanoma.

Learn more >>